Skip to main navigation

Investors

News Archive
Past Events and Presentations
Stock History

News Archive

News Archive

Items Per Page

Year

Apr 29, 2008

Mylan Announces Final FDA Approval for Trandolapril Tablets

Apr 29, 2008

Mylan Appoints Michael J. Monroe Senior Vice President for Global Public Affairs

Apr 21, 2008

Mylan Announces Final FDA Approval for Felodipine Extended-Release Tablets, USP

Feb 27, 2008

Mylan Announces Appointment of Jagdish Dore' as CEO and Managing Director of Matrix Laboratories

Feb 27, 2008

Mylan Announces Amendment to Bystolic(TM) (Nebivolol) Agreement

Feb 27, 2008

Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter

Feb 26, 2008

Mylan Announces Appointment of Patrick Vink as Senior Vice President in New Position of Global Head of Biologics

Feb 21, 2008

Mylan Revises Timing of Its Financial Results Conference Call for the Quarter and Nine Months Ended Dec. 31, 2007, to 5 p.m. ET

Feb 14, 2008

Mylan Confirms Its Matrix Design Fentanyl Patch Is Not Included In the Widespread Recall Announced February 12th

Feb 08, 2008

Mylan Restores Availability of Generic Levothyroxine in Florida

Pagination

First page
Previous page
…
Page 92
Page 93
Page 94
Page 95
Current page 96
Page 97
Page 98
Page 99
Page 100
…
Next page
Last page

Share

Utility Nav

Privacy Statement
Terms and Conditions

©2024 Mylan N.V. All rights reserved. The Mylan logo is a registered trademark of Mylan Inc.